
	Where results make sense

Topic: IBZM

Related Topics

FDG

Dopamine

SPECT

Imp

In the News (Tue 22 Dec 09)

Northern Trust

Marvin Harrison

Peter Chernin

Gary Locke

Match Play

Penelope Cruz

Mickey Rourke

AR Rahman

Danny Boyle

Hugh Jackman

	Tramadol, buy tramadol, antibiotics, Weight Loss drugs, weight loss herbs, weight loss herbal formula, weight loss, ... (Site not responding. Last check: 2007-11-05)
		Age-corrected baseline IBZM binding in the striatum was significantly lower in treatment responders than in depressed non-responders and control subjects.
		Furthermore, in the depressive group there was a significant linear correlation between treatment response and change of D2 receptor binding during treatment in the basal ganglia.
		IBZM binding increased in treatment responders and decreased in non-responders.
	rx-drugs-usa.com /paxil-online-rx/paxil-online-rx.5.html (690 words)

	P277 : Value of 123I-FP-CIT and 123I-IBZM SPET for the diagnosis of corticobasal degeneration (CBD) (Site not responding. Last check: 2007-11-05)
		The aim of the study was to evaluate the diagnostic accuracy of FP-CIT and IBZM SPET for detection of CBD.
		In IBZM SPET an reduced D2 receptor binding was found in 3 of 8 CBD patients using the iteratively determined discrimination thresholds of 1.5 for striatal and putaminal BRs and of 1.0 for putamen-to-caudate ratio.
		In 6 of 8 patients a reduced glucose metabolism was observed in the parietal lobes and thalamus.
	www.thieme.de /abstracts/aktneu/abstracts2003/daten/p277.html (375 words)

	[No title] (Site not responding. Last check: 2007-11-05)
		Specific IBZM binding was calculated as the region of interest to colcerebellum ratio.
		In the frontal lobe, the average IBZM binding decreased by 11% from 1.15 ± 0.04 before to 1.03 ± 0.11 after treatment, whereas in the basal ganglia the average IBZM binding remained unchanged.
		Clinical improvement of depressive symptoms might be associated with a decrease of IBZM binding to D2 receptors corresponding to an increase in synaptic dopamine concentration or a downregulation of dopamine receptors.
	www.elsevier.com /cdweb/journals/0924977X/articles/5/3/0924977X9590440.abstract.en (266 words)

	Low striatal D2 receptor binding as assessed by [123I] IBZM SPECT in patients with writer's cramp (Site not responding. Last check: 2007-11-05)
		Horstink, C.A., Praamstra, P., Horstink, M.W.I.M., Berger, H.J.C., Booij, J., and Van Royen, E.A. Low striatal D2 receptor binding as assessed by [123I] IBZM SPECT in patients with writer's cramp.
		In view of the possible involvement of dopaminergic striatal receptors in dystonia, we measured the availability of striatal D2 receptors in patients with writer's cramp using [123I] IBZM SPECT.
		Our results suggest that the striatal dopaminergic system is involved in writer's cramp given that patients with writer's cramp have a significantly lower level of striatal [123I IBZM binding than controls.
	www.nici.kun.nl /Publications/1997/11278.html (172 words)

	Long-term treatment with the tetrahydropyridine analog ( HPTP) of haloperidol influences dopamine ligand binding in ...
		The effect of long-term HPTP treatment on the central nervous system of baboons (Papio ursinus) was studied using [123I]iodobenzamide (IBZM) and single photon emission computed tomography (SPECT) at 1-14 weeks after termination of HPTP treatment.
		Striatal dopamine receptor binding was measured semiquantitatively by calculating the IBZM count rate ratios of the basal ganglia to frontal cortex and basal ganglia to cerebellum.
		Time activity curves of IBZM from the brain structures suggest that HPTP treatment results in a marked reduction in central dopamine ligand binding, and in particular D2-like receptor binding.
	www.pdg.cnb.uam.es /UniPub/iHOP/gp/1001453.html (250 words)

	CBDB SPECT Program
		IBZM studies in normal volunteers, Parkinson’s Disease patients with clinical asymmetrical presentation, and identical twins with Tourette’s syndrome have established that this technique is able to provide a sensitive measure of clinically meaningful dopamine function.
		- SPECT imaging of D2 receptors in Mz twins discordant for severity of Tourette’s syndrome: significant correlation of increased IBZM uptake in caudate with degree of discordance for tic severity.
		- Beta-CIT and IBZM SPECT of primates with neonatal and adult hippocampal lesions: Effect on striatal dopaminergic neurons: Preliminary results suggest that striatal dopamine binding was decreased in monkeys with neonatal lesion as compared to adult lesions, whereas dopamine transporter binding was either reduced or not different in adult lesions compared to neonatal and controls.
	cbdb.nimh.nih.gov /spect.htm (1005 words)

	Behavioral Changes and [123I]IBZM Equilibrium SPECT Measurement of Amphetamine-Induced Dopamine Release in Rhesus ...
		The term sensitization refers to the enhanced behavioral response to psychomotor stimulants, such as d-amphetamine (AMPH) and cocaine, that is shown by subjects who have had prior exposure to these agents (for review see Robinson and Becker 1986; Kalivas and Stewart 1991).
		For scans in which plasma samples were taken, fluctuations in plasma concentrations of the parent compound, i.e., altered hepatic metabolism of IBZM, did not account for changes in the binding of IBZM to striatal D2 dopamine receptors.
		Finally, as IBZM is not specific to the D2 receptor but also has an affinity for D3 receptors, changes in D2 receptor densities might not be easy to detect.
	www.nature.com /cgi-taf/dynapage.taf?file=/npp/journal/v22/n1/full/1395404a.html (4728 words)

	Revista Medicina Nuclear Alasbimn Journal, Year 5, Nº 17, September, 2002
		Tc-99m TRODAT-1 and I-123 IBZM are potential agents for dopamine transporter (DAT) and dopamine receptor (DR) SPECT, respectively.
		Tc-99m TRODAT-1 (925 MBq) and then I-123 IBZM (259 MBq) SPECT were performed separately within a month using a dual-head camera equipped with an ultra-high resolution fan beam collimator (Helix SPX, Elscint).
		The averaged SUR of IBZM, however, was significantly decreased only in the contralateral ST of the stage II patients.
	www.alasbimnjournal.cl /revistas/17/abstracts-poster/537neuro-psychiatric-disorders.html (314 words)

	[No title] (Site not responding. Last check: 2007-11-05)
		Specific IBZM binding was calculated as the region of interest to cerebellum ratio.
		Within the basal ganglia, the average IBZM binding remained unchanged in the group as a whole.
		However, there was a significant correlation between the change of striatal IBZM binding and the improvement in psychopathology (p _ 0.05), i.e., responders demonstrated a 20% increase and nonresponders a 10-20% decrease or no change of striatal and cingulate IBZM binding.
	www.elsevier.com /cdweb/journals/0924977X/articles/6/S4/0924977X9683033.abstract.en (235 words)

	CNR-PFI UO BATTISTIN Leontino
		IBZM SPECT was used to determine D2 receptors number in basal ganglia regions of Alzheimer patients without overt extrapyramidal symptomatology.
		In Parkinson's dissease patients, striatal D2 receptors number was determined in groups of patients separated on the basis of their response to therapy.
		Significantly reduced IBZM striatal uptake was found only in the group of patients with a fluctuating response to levodopa.
	www.aging.cnr.it /uoe/uo2_022.htm (1251 words)

	NRU's publication database (Site not responding. Last check: 2007-11-05)
		The aim of the present study was to characterize the binding of IBZM to dopaminergic receptor subtypes as a means of elucidating which receptor subtypes are visualized and examined by [(123)I]IBZM.
		The affinity of IBZM for each of the major human dopamine receptors (D1, D2(short), D3, D4(4.
		Assays were performed at 25 degrees C. These experiments show that for IBZM K(i) values were 1.6 nM for dopamine D2(s) receptors and 2.2 nM for dopamine D3 receptors.
	neuro.pet.rh.dk /cgi-bin/extract?videbaekc2000a (243 words)

	Correlation of Scintigraphic Results Using 123I-Methoxybenzamide with Hormone Levels and Tumor Size Response to ...
		I-IBZM pituitary uptake and the response to treatment with
		I-IBZM (right) in two exemplary patients with pituitary adenoma.
		I-IBZM (28), and the possibility to use double- and triple-headed
	jcem.endojournals.org /cgi/content/full/83/1/248 (2594 words)

	link (Site not responding. Last check: 2007-11-05)
		Evaluation of [123I] IBZM Pinhole-SPECT and MRI co-registration as an useful method for the in vivo detection of striatal dopamine D2 receptor distribution.
		Striatal dopamine D2 receptor function measured by in vivo [123I] IBZM Pinhole-SPECT correlates with ex-vivo quantification of striatal medium-sized spiny neurons.
		Poster Preis der Österreichischen Parkinson-Gesellschaft, Pörtschach 2004 verliehen an meine Dissertantin Frau Dr. Sonja Scholz zum Thema: Striatal dopamine D2 receptor function measured by in vivo [123I] IBZM Pinhole-SPECT correlates with ex-vivo quantification of striatal medium-sized spiny neurons.
	homepage.uibk.ac.at /homepage/c519/c51960/cv.html (1713 words)

	Abstract 8 (Site not responding. Last check: 2007-11-05)
		The aim of this work was to compare the capability of IBZM and ILIS in assessing DR2 in patients with degenerative extra-pyramidal syndromes.
		Methods: 69 patients with an extra-pyramidal syndrome were included and evaluated with the Unified Parkinson Disease Rate Scale and Hoehn and Yahr scale: group 1: PD n=37, group 2: PSP n=12, AMS n=16, LBD n=2 and other extra-pyramidal syndromes n=4.
		Standardized geometrical regions of interest (ROI) were placed onto the striatum and occipital cortex (2) The ratio between striatal and occipital ROI counting (S/O) was calculated as an index of the binding potential of each ligand to DR2.
	brain99.pet.rh.dk /scientific/abstracts/000108.html (287 words)

	Clinical Trial: Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients
		[I-123] IBZM is a radioligand that has been widely employed for SPECT imaging of dopamine type 2 and type 3 receptors (D2 and D3, respectively) and fluctuations in levels of endogenous dopamine.
		Pharmacological effects of IBZM are unlikely due to the minimal amounts used and have not been observed.
		We propose to use [I-123] IBZM SPECT to explore following questions: 1) Can a previously found relationship between N-acetylaspartate (NAA) measures in the dorsolateral prefrontal cortex and striatal dopamine activity in patients with schizophrenia be replicated and is it also found in normal subjects?
	clinicaltrials.gov /show/NCT00001320 (1008 words)

	SPECT Imaging
		I] IBZM competitively binds to these receptors, meaning that one [
		I] IBZM molecule will try to bind to the receptor the same as dopamine will.
		I] IBZM in the blood, or the initial amounts of D
	www.macalester.edu /psychology/whathap/ubnrp/dopahypoweb04/steve_page_2.html (413 words)

	Current Pharmaceutical Design, Volume 9, No. 8, 2003 (Site not responding. Last check: 2007-11-05)
		I]iodobenzamide (IBZM), was found to have moderate putamen-to-cerebellum ratio in rat and human brain.
		SAR studies of the metabolites of remoxipride led to the discovery of the 3-methoxy isomer, isoremoxipride (FLB-457) and its corresponding 6-hydroxy analog, FLB-463, both having affinities for the dopamine D
		In 1988, epidepride was independently prepared and radiolabeled in three separate laboratories in Stockholm, Berkeley, and Nashville.
	www.bentham.org /cpd/cpd9-8.htm (1109 words)

	Thieme-connect - Abstract (Site not responding. Last check: 2007-11-05)
		The change in striatal IBZM binding between pre- and post-TMS scans was used as a measure of endogenous dopamine release triggered by TMS.
		Four studies showed a mean 2% (range: 1.2 to 4.2) reduction in IBZM binding to striatal D
		The reduction of IBZM binding is suggestive of an increase in endogenous dopaminergic stimulation.
	www.thieme-connect.com /ejournals/abstract/pharmaco/doi/10.1055/s-2003-825459 (163 words)

	Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans
		Unlabeled IBZM and raclopride were obtained from Research Biochemicals International, Natick, MA.
		AMPT effects on clinical ratings, plasma catecholamine metabolite, and scan measurements were assessed by repeated measures ANOVA.
		I] IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.
	www.nature.com /npp/journal/v17/n3/full/1395024a.html (6895 words)

	Alcohol, drugs, and tobacco research 2001-2002: Dopamine and opiate craving in the human brain: An imaging approach
		Instant opiate craving is associated with an increased cue-elicited endogenous dopamine release in the striatum and with increased activity of the nucleus accumbens.
		The relation between craving (using self-report) and D2 receptor availability will be studied using ligand [123I]iodobenzamide (IBZM) and single photon emission computed tomography (SPECT).
		Genetic influences on D2 receptor availability will be studied by measuring the the presence of the A1 allele (a polymorphism in the noncoding region of the D2 receptor gene).
	www.beta.nl /regado2002_book/projects/01_Franken_2972_2972_AB.htm (280 words)

	FDG-PET and IBZM-SPECT Suggest Reduced Thalamic Activity but No Dopaminergic Dysfunction in Chronic Alcohol ...
		Magnetic resonance imaging revealed a generalized cortical brain atrophy without any evidence for focal gray or white matter lesions.
		I]iodobenzamide (IBZM) SPECT was performed after 2 weeks of abstinence in the drug-naive patient on a triple-head gamma camera (Picker Prism 3000 XP, equipped with high-resolution fan beam collimators) after iv administration of 185 MBq [
		Images were acquired 2 hours after administration and were reconstructed by use of filtered backprojection.
	neuro.psychiatryonline.org /cgi/content/full/12/2/287 (680 words)

	PMID: 10688103: Automatic SPECT technique for diagnosing PD
		This study presents a new, objective, automated technique for semiquantitative analysis of dopamine receptor density, as applied to the differential diagnosis of parkinsonism.
		METHODS: Dopamine receptor density measured by 123I-iodobenzamide (IBZM) SPECT was retrospectively analyzed in nonidiopathic parkinsonism (NIPS), in Parkinson's disease (PD), and in healthy volunteers (n = 19, 38, and 13, respectively).
		A mean template was created from coregistered control studies.
	parkinsons-information-exchange-network-online.com /parkmail2/2000a/msg02921.html (442 words)

	Radiopharmaceutical Chemistry Section - University of Pennsylvania (Site not responding. Last check: 2007-11-05)
		When the tracers are tested in humans using Single Photon Emission Computed Tomography (SPECT), they may provide diagnostic information not attainable by other imaging techniques.
		In the past ten years, a number of new I-123 labeled CNS receptor imaging agents for SPECT were developed in this laboratory and successfully tested in humans, including TISCH (dopamine D1 receptor), IBZM, IBF and FIDA2 (dopamine D2 and D3 receptors) and IPT (dopamine transporter, DAT).
		The dopamine D2 imaging agent- IBZM is currently available commercially in Europe through Cygne (Eindhoven, Netherlands), and the other dopamine D2 receptor imaging agent-IBF is being developed by Nihon Medi-Physics (Tokyo, Japan).
	sunmac.spect.upenn.edu /Hank_Kung.html (339 words)

	SPM Extensions (Site not responding. Last check: 2007-11-05)
		No external Matlab toolboxes required; preliminary tests using SPM2 were OK.
		Summary: A fully automated system for evaluation of IBZM SPECT studies.
		It includes automated procedures for realignment and summation of multiple frames (for motion correction), stereotactical normalization, scaling, VOI-analysis of striatal IBZM uptake, classification of striatal IBZM-uptake, and standardized display.
	www.fil.ion.ucl.ac.uk /spm/ext (2242 words)

	ADHD and Dopamine -- Neurotransmitter.net
		Nine children (six males, three females; mean age 9.8 years, SD 2.3 years) with ADHD participated.
		All underwent iodobenzamide (123I IBZM) brain SPECT within 2 hours following intravenous injection of 123I IBZM before and 3 months after methylphenidate therapy.
		A semiquantitative approach was used to generate indices of specific D2 receptor binding in the basal ganglia.
	www.neurotransmitter.net /adhdda.html (16821 words)

	In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with ...
		In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas
		tumor, and SPECT showed a very intense concentration of IBZM at the level
		scintigraphy with IBZM has given information on the density of dopamine
	jcem.endojournals.org /cgi/content/abstract/80/8/2523 (396 words)

	NeuroPhysics (Site not responding. Last check: 2007-11-05)
		Normal control scanned with the neuroreceptor ligand IBZM
		This study demonstrates the rapid repeat scan capabilities of the NeuroFocus™.
		Data courtesy of NeuroSPECT Center, Yale University School of Medicine (Paul Hoffer, M.D.)
	neurophysics.com /neuro/studies/clinical/ibzm.html (82 words)

	In Vivo Evidence for Dopamine-Mediated Internalization of D2-Receptors after Amphetamine: Differential Findings with ...
		ligands (raclopride, IBZM) lose access to the shifted receptors,
		Address correspondence to: Nathalie Ginovart, PET center, Centre for Addiction and Mental Health, 250 College Street Toronto, Ontario M5T 1R8, Canada.
		PET, positron emission tomography; SPECT, single photon emission computed tomography; DA, dopamine; IBZM, iodobenzamide; NMSP, N-methyl-spiperone; GPP(NH)p, 5'-guanylylimidodiphosphate.
	molpharm.aspetjournals.org /cgi/content/full/63/2/456 (4842 words)

Try your search on: Qwika (all wikis)